Harnessing large language models' zero-shot and few-shot learning capabilities for regulatory research.
利用大型語言模型的零-shot和少-shot學習能力進行監管研究。
Brief Bioinform 2024-08-23
Evaluating the Feasibility of ChatGPT in Healthcare: An Analysis of Multiple Clinical and Research Scenarios.
評估 ChatGPT 在醫療保健領域的可行性:對多種臨床和研究情境的分析。
J Med Syst 2023-12-31
A framework enabling LLMs into regulatory environment for transparency and trustworthiness and its application to drug labeling document.
將此醫學文章的標題翻譯為繁體中文:「將LLMs引入監管環境以提升透明度和可信度的框架及其應用於藥物標籤文件」。
Regul Toxicol Pharmacol 2024-04-05
Using Large Language Models to Support Content Analysis: A Case Study of ChatGPT for Adverse Event Detection.
使用大型語言模型支援內容分析:以 ChatGPT 在不良事件檢測上的案例研究。
J Med Internet Res 2024-05-02
Integrating human expertise & automated methods for a dynamic and multi-parametric evaluation of large language models' feasibility in clinical decision-making.
將人類專業知識與自動化方法整合,以動態和多參數評估大型語言模型在臨床決策中的可行性。
Int J Med Inform 2024-05-29
The potential and pitfalls of using a large language model such as ChatGPT, GPT-4, or LLaMA as a clinical assistant.
使用大型語言模型如ChatGPT、GPT-4或LLaMA作為臨床助手的潛力與陷阱。
J Am Med Inform Assoc 2024-07-17
Comparing a Large Language Model with Previous Deep Learning Models on Named Entity Recognition of Adverse Drug Events.
比較大型語言模型與先前深度學習模型在不良藥物事件命名實體識別上的表現。
Stud Health Technol Inform 2024-08-23
Performance of the ChatGPT large language model for decision support in community pharmacy.
ChatGPT 大型語言模型在社區藥局決策支持中的表現。
Br J Clin Pharmacol 2024-08-27
Unlocking the potential of advanced large language models in medication review and reconciliation: A proof-of-concept investigation.
釋放先進大型語言模型在藥物審查和調解中的潛力:一項概念驗證研究。
Explor Res Clin Soc Pharm 2024-09-11